Price to Sales (P/S)
since 2005
Calculation
Illumina Inc., P/S, long-term trends, calculation
| P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Revenue1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2021 | 22.26 | = | 494.24 | ÷ | 22.20 | 22.20 | = | 3,239 | ÷ | 145,900,000 | |
| Feb 11, 2020 | 12.28 | = | 296.00 | ÷ | 24.10 | 24.10 | = | 3,543 | ÷ | 147,000,000 | |
| Feb 12, 2019 | 12.89 | = | 292.20 | ÷ | 22.67 | 22.67 | = | 3,333 | ÷ | 147,000,000 | |
| Feb 13, 2018 | 11.77 | = | 220.44 | ÷ | 18.72 | 18.72 | = | 2,752 | ÷ | 147,000,000 | |
| Feb 14, 2017 | 10.03 | = | 164.46 | ÷ | 16.39 | 16.39 | = | 2,398 | ÷ | 146,300,000 | |
| Mar 2, 2016 | 10.41 | = | 157.20 | ÷ | 15.10 | 15.10 | = | 2,220 | ÷ | 147,000,000 | |
| Feb 18, 2015 | 15.34 | = | 198.62 | ÷ | 12.94 | 12.94 | = | 1,861 | ÷ | 143,800,000 | |
| Feb 18, 2014 | 15.37 | = | 170.40 | ÷ | 11.09 | 11.09 | = | 1,421 | ÷ | 128,200,000 | |
| Feb 15, 2013 | 5.26 | = | 48.73 | ÷ | 9.26 | 9.26 | = | 1,149 | ÷ | 124,040,754 | |
| Feb 24, 2012 | 5.94 | = | 51.22 | ÷ | 8.63 | 8.63 | = | 1,056 | ÷ | 122,327,021 | |
| Feb 28, 2011 | 9.81 | = | 69.40 | ÷ | 7.07 | 7.07 | = | 903 | ÷ | 127,626,004 | |
| Feb 26, 2010 | 6.56 | = | 36.32 | ÷ | 5.54 | 5.54 | = | 666 | ÷ | 120,298,934 | |
| Feb 26, 2009 | 6.79 | = | 32.16 | ÷ | 4.73 | 4.73 | = | 573 | ÷ | 121,077,875 | |
| Feb 26, 2008 | 11.28 | = | 37.23 | ÷ | 3.30 | 3.30 | = | 367 | ÷ | 111,090,078 | |
| Feb 28, 2007 | 10.93 | = | 16.80 | ÷ | 1.54 | 1.54 | = | 185 | ÷ | 120,098,536 | |
| Mar 6, 2006 | 14.36 | = | 12.79 | ÷ | 0.89 | 0.89 | = | 74 | ÷ | 82,538,624 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Illumina Inc. Annual Report.
An examination of the financial metrics from 2006 to 2021 reveals a significant expansion in both market valuation and revenue generation, characterized by distinct periods of valuation volatility and fundamental growth.
- Share Price Trajectory
- The share price experienced substantial long-term growth, ascending from 12.79 USD in 2006 to a peak of 494.24 USD by February 2021. While the growth was steady in the early years, a more aggressive acceleration in price is observed starting in 2014.
- Sales per Share Performance
- Revenue generation per share demonstrated consistent and nearly uninterrupted growth throughout the analyzed period. Sales per share increased from 0.89 USD in 2006 to 22.20 USD in 2021, reflecting a robust expansion in the company's operational scale and revenue capacity.
- Price to Sales (P/S) Ratio Trends
- The P/S ratio transitioned through three distinct phases. First, a contraction phase occurred between 2006 and 2013, during which the ratio declined from 14.36 to a period low of 5.26, suggesting that sales growth outpaced share price appreciation. Second, a sharp revaluation occurred in 2014, where the ratio jumped to 15.37. Third, a period of elevated valuation followed, culminating in a peak ratio of 22.26 in 2021. This final peak represents the highest valuation multiple relative to sales in the entire recorded sequence, indicating a significant increase in the market premium assigned to each dollar of revenue.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Comparison to Competitors
Illumina Inc., P/S, long-term trends, comparison to competitors
| Illumina Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2021 | 22.26 | 4.05 | 5.64 | 3.16 | 7.01 | 8.06 | 3.24 | 5.15 | 3.93 | 4.42 | 6.24 | 5.52 | 8.82 |
| Feb 11, 2020 | 12.28 | 4.22 | 6.03 | 5.52 | 6.29 | 6.03 | 4.00 | 4.79 | 4.33 | 3.66 | 5.34 | 4.83 | 14.95 |
| Feb 12, 2019 | 12.89 | 3.58 | 5.22 | 3.67 | 3.97 | 5.15 | 3.84 | 4.45 | 4.92 | 4.49 | 6.62 | 4.24 | 15.54 |
| Feb 13, 2018 | 11.77 | 6.67 | 5.82 | 5.02 | 3.70 | 3.71 | 4.10 | 4.56 | 3.68 | 4.05 | 5.92 | 4.01 | 16.42 |
| Feb 14, 2017 | 10.03 | 3.84 | 5.65 | 4.72 | 3.48 | 4.18 | 3.08 | 4.62 | 4.54 | 3.84 | 7.86 | 3.37 | 12.51 |
| Mar 2, 2016 | 10.41 | 3.83 | 5.28 | 6.07 | 2.91 | 4.02 | 3.80 | 4.13 | 3.56 | 3.76 | 9.38 | 3.05 | 20.38 |
| Feb 18, 2015 | 15.34 | 4.90 | 6.13 | 6.28 | 3.09 | 4.03 | 6.36 | 3.77 | 3.93 | 4.24 | 14.62 | 3.06 | 47.41 |
| Feb 18, 2014 | 15.37 | 4.31 | 5.22 | 5.48 | 2.78 | 2.81 | 11.95 | 3.63 | 3.78 | 3.97 | 15.52 | 3.74 | 16.53 |
| Feb 15, 2013 | 5.26 | 3.30 | 4.09 | 3.40 | 2.32 | 2.71 | 6.95 | 3.17 | 2.73 | 3.34 | 11.66 | 2.12 | 6.60 |
| Feb 24, 2012 | 5.94 | — | 3.52 | 2.63 | 2.28 | 1.87 | 4.22 | 2.75 | 2.43 | 2.37 | 20.90 | 1.77 | 5.61 |
| Feb 28, 2011 | 9.81 | — | 3.32 | 2.23 | 2.48 | 1.73 | 4.19 | 2.65 | 2.18 | 2.27 | 7.38 | 2.00 | 56.82 |
| Feb 26, 2010 | 6.56 | — | 3.88 | 2.27 | 2.16 | 1.82 | 6.64 | 2.82 | 4.23 | 2.83 | 5.74 | 1.98 | 80.12 |
| Feb 26, 2009 | 6.79 | — | 3.44 | 1.96 | 1.30 | 1.66 | 8.03 | 2.37 | 2.14 | 1.72 | 5.17 | 1.44 | 28.70 |
| Feb 26, 2008 | 11.28 | — | 3.46 | 2.30 | 2.16 | 3.05 | 10.90 | 2.95 | 4.04 | 3.11 | 11.94 | 2.40 | 12.17 |
| Feb 28, 2007 | 10.93 | — | 5.41 | 3.07 | 2.30 | 3.80 | 12.67 | 3.53 | 4.23 | 3.67 | 19.70 | 5.05 | 17.58 |
| Mar 6, 2006 | 14.36 | — | 7.24 | 2.34 | 2.40 | 4.31 | 15.36 | 3.49 | 3.50 | 3.77 | 14.06 | 2.15 | 26.93 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Illumina Inc., P/S, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Illumina Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 17, 2021 | 22.26 | 4.90 |
| Feb 11, 2020 | 12.28 | 4.88 |
| Feb 12, 2019 | 12.89 | 4.54 |
| Feb 13, 2018 | 11.77 | 4.60 |
| Feb 14, 2017 | 10.03 | 4.29 |
| Mar 2, 2016 | 10.41 | 4.10 |
| Feb 18, 2015 | 15.34 | 4.54 |
| Feb 18, 2014 | 15.37 | 4.30 |
| Feb 15, 2013 | 5.26 | 3.25 |
| Feb 24, 2012 | 5.94 | 2.58 |
| Feb 28, 2011 | 9.81 | 2.44 |
| Feb 26, 2010 | 6.56 | 3.00 |
| Feb 26, 2009 | 6.79 | 2.22 |
| Feb 26, 2008 | 11.28 | 3.19 |
| Feb 28, 2007 | 10.93 | 3.88 |
| Mar 6, 2006 | 14.36 | 3.84 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Industry (Health Care)
Illumina Inc., P/S, long-term trends, comparison to industry (health care)
| Illumina Inc. | Health Care | |
|---|---|---|
| Feb 17, 2021 | 22.26 | 3.31 |
| Feb 11, 2020 | 12.28 | 3.21 |
| Feb 12, 2019 | 12.89 | 3.07 |
| Feb 13, 2018 | 11.77 | 3.06 |
| Feb 14, 2017 | 10.03 | 2.80 |
| Mar 2, 2016 | 10.41 | 2.72 |
| Feb 18, 2015 | 15.34 | 3.08 |
| Feb 18, 2014 | 15.37 | 2.81 |
| Feb 15, 2013 | 5.26 | 2.20 |
| Feb 24, 2012 | 5.94 | 1.90 |
| Feb 28, 2011 | 9.81 | 1.80 |
| Feb 26, 2010 | 6.56 | 2.08 |
| Feb 26, 2009 | 6.79 | 1.70 |
| Feb 26, 2008 | 11.28 | 2.42 |
| Feb 28, 2007 | 10.93 | 2.85 |
| Mar 6, 2006 | 14.36 | 3.17 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).